↓ Skip to main content

Upregulation of SATB1 is associated with the development and progression of glioma

Overview of attention for article published in Journal of Translational Medicine, July 2012
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
51 Dimensions

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Upregulation of SATB1 is associated with the development and progression of glioma
Published in
Journal of Translational Medicine, July 2012
DOI 10.1186/1479-5876-10-149
Pubmed ID
Authors

Sheng-Hua Chu, Yan-Bin Ma, Dong-Fu Feng, Hong Zhang, Zhi-An Zhu, Zhi-Qiang Li, Pu-Cha Jiang

Abstract

Special AT-rich sequence-binding protein-1 (SATB1) has been reported to be expressed in several human cancers and may have malignant potential. This study was aimed at investigating the expression and potential role of SATB1 in human glioma.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 31 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 19%
Student > Ph. D. Student 5 16%
Researcher 5 16%
Student > Master 5 16%
Librarian 2 6%
Other 4 13%
Unknown 4 13%
Readers by discipline Count As %
Agricultural and Biological Sciences 8 26%
Biochemistry, Genetics and Molecular Biology 7 23%
Medicine and Dentistry 7 23%
Nursing and Health Professions 1 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 2 6%
Unknown 5 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 October 2012.
All research outputs
#9,958,552
of 12,440,173 outputs
Outputs from Journal of Translational Medicine
#2,263
of 2,445 outputs
Outputs of similar age
#90,766
of 128,727 outputs
Outputs of similar age from Journal of Translational Medicine
#12
of 16 outputs
Altmetric has tracked 12,440,173 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,445 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one is in the 2nd percentile – i.e., 2% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 128,727 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.